These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 16638400)

  • 1. Pimecrolimus 1 percent cream in the treatment of psoriasis in a child.
    Mansouri P; Farshi S
    Dermatol Online J; 2006 Feb; 12(2):7. PubMed ID: 16638400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pimecrolimus 1% cream for anogenital lichen sclerosus in childhood.
    Boms S; Gambichler T; Freitag M; Altmeyer P; Kreuter A
    BMC Dermatol; 2004 Oct; 4(1):14. PubMed ID: 15485581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.
    Gribetz C; Ling M; Lebwohl M; Pariser D; Draelos Z; Gottlieb AB; Zaias N; Chen DM; Parneix-Spake A; Hultsch T; Menter A
    J Am Acad Dermatol; 2004 Nov; 51(5):731-8. PubMed ID: 15523351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pimecrolimus 1% cream in the treatment of facial psoriasis: a 16-week open-label study.
    Jacobi A; Braeutigam M; Mahler V; Schultz E; Hertl M
    Dermatology; 2008; 216(2):133-6. PubMed ID: 18216475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, single-blind, placebo-controlled, split-face study with pimecrolimus cream 1% for papulopustular rosacea.
    Karabulut AA; Izol Serel B; Eksioglu HM
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):729-34. PubMed ID: 18328059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term management of facial atopic eczema with pimecrolimus cream 1% in paediatric patients with mild to moderate disease.
    Zuberbier T; Bräutigam M
    J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):718-21. PubMed ID: 18312323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis.
    Sigurgeirsson B; Ho V; Ferrándiz C; Andriano K; Grinienko A; Jimenez P;
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1290-301. PubMed ID: 18624866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of pimecrolimus cream 1% for the treatment of mild to moderate atopic dermatitis.
    Hebert AA
    Clin Ther; 2006 Dec; 28(12):1972-82. PubMed ID: 17296454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial.
    Gollnick H; Kaufmann R; Stough D; Heikkila H; Andriano K; Grinienko A; Jimenez P;
    Br J Dermatol; 2008 May; 158(5):1083-93. PubMed ID: 18341665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical pimecrolimus in the treatment of genital lichen planus: a prospective case series.
    Lonsdale-Eccles AA; Velangi S
    Br J Dermatol; 2005 Aug; 153(2):390-4. PubMed ID: 16086755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study.
    Yan AC; Honig PJ; Ming ME; Weber J; Shah KN
    Arch Dermatol; 2010 Jan; 146(1):57-62. PubMed ID: 20083693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial.
    Lee DH; Li K; Suh DH
    Br J Dermatol; 2008 May; 158(5):1069-76. PubMed ID: 18363758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of pimecrolimus cream 1% in adult patients with vitiligo: results of a randomized, double-blind, vehicle-controlled study.
    Dawid M; Veensalu M; Grassberger M; Wolff K
    J Dtsch Dermatol Ges; 2006 Nov; 4(11):942-6. PubMed ID: 17081269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pimecrolimus cream 1% in erosive oral lichen planus--a prospective randomized double-blind vehicle-controlled study.
    Volz T; Caroli U; Lüdtke H; Bräutigam M; Kohler-Späth H; Röcken M; Biedermann T
    Br J Dermatol; 2008 Sep; 159(4):936-41. PubMed ID: 18647310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of facial atopic dermatitis in children who are intolerant of, or dependent on, topical corticosteroids: a randomized, controlled clinical trial.
    Hoeger PH; Lee KH; Jautova J; Wohlrab J; Guettner A; Mizutani G; Hultsch T
    Br J Dermatol; 2009 Feb; 160(2):415-22. PubMed ID: 19067708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of pimecrolimus cream 1% in adolescents and adults with head and neck atopic dermatitis and intolerant of, or dependent on, topical corticosteroids.
    Murrell DF; Calvieri S; Ortonne JP; Ho VC; Weise-Riccardi S; Barbier N; Paul CF
    Br J Dermatol; 2007 Nov; 157(5):954-9. PubMed ID: 17935515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label efficacy pilot study with pimecrolimus cream 1% in adults with facial seborrhoeic dermatitis infected with HIV.
    de Moraes AP; de Arruda EA; Vitoriano MA; de Moraes Filho MO; Bezerra FA; de Magalhães Holanda E; de Moraes ME
    J Eur Acad Dermatol Venereol; 2007 May; 21(5):596-601. PubMed ID: 17447972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pimecrolimus 1% cream for the treatment of atopic dermatitis.
    Wolff K
    Skin Therapy Lett; 2005 Oct; 10(8):1-6. PubMed ID: 16292456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
    de Bruin-Weller MS; Bruijnzeel-Koomen CA
    Ned Tijdschr Geneeskd; 2005 May; 149(20):1096-100. PubMed ID: 15932135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.